HPV prevention
Other · 2011–2011
1decision
1medicine
0carried consumer input
0individual submissions
Every decision here pre-dates the consumer comments facility, so no input would be recorded either way.
Every decision
| Medicine | Meeting | Outcome | Consumer input |
|---|---|---|---|
| quadrivalent human papillomavirus (Types 6, 11, 16, 18) recombinant vaccine prevention of human papillomavirus (HPV) in males 12-13 years of age and a catch-up program over 2 years for Year 9 males | Nov 2011 | Recommended with restriction | unclear |
Conditions are classified by a language model from the indication text of each submission, so an individual label here can be wrong. Consumer input is read from the document's own consumer comments section: 0 of 0 decisions since 2014 carried some. Silence means no comment reached the committee through that facility, not that nobody was affected. More on how this was built.